Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

This study has been completed.

Study NCT00137826 Information provided by Dana-Farber Cancer Institute

First Received: August 29, 2005 Last Updated: December 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2009
Primary Completion Date:	March 2007 (Final data collection date for primary outcome measure)